title: Peripheral neuropathy: a complication of systemic sclerosis.
abstract: We performed bedside testing for peripheral neuropathy in our systemic sclerosis (SSc) population to determine whether foot care guidelines should be developed for SSc. Twenty consecutive SSc patients and 20 healthy control (HC) patients were evaluated for peripheral neuropathy in both feet using the 10-g Semmes-Weinstein monofilament examination (SWME) and 128 Hz vibration sensation using the on-off method. Independent, blinded, vibratory sensation, and SWME evaluations were performed on each subject by two investigators who had completed a training session to standardize each exam. An additional consecutive 20 patients with type 2 diabetes mellitus (DM) were examined by a diabetologist to compare with peripheral neuropathy prevalence in SSc patients. We examined the inter-rater variability using Cohen's kappa. We compared SWME and vibratory sensation in SSc to HC using Fisher's exact. The t test was used to compare duration of disease and modified Rodnan skin score (mRSS) for those with abnormal SWME or vibratory sensation. Two of 20 SSc patients reported sensory foot symptoms consistent with peripheral neuropathy prior to the examination. Inter-rater agreement for both SWME and vibratory sensation was strong (kappa: 0.72 and 0.83, respectively). Two HC and 12 SSc patients demonstrated abnormal vibratory sense (one-sided Fishers' exact, p < 0.002). No HC and four SSc patients had abnormal monofilament exams (one-sided Fisher's exact, p = 0.053). Neither mRSS (p = 0.28) nor duration of non-Raynauds (p = 0.07) symptoms differed between those with peripheral neuropathy and those without. Duration of Raynaud's symptoms were clinically significantly associated with presence of peripheral neuropathy (p = 0.04). The prevalence of sensory loss to monofilament in SSc was identical to DM patients (4/20). SSc patients have a considerable prevalence of pedal peripheral neuropathy as detected by loss of vibratory sensation or inability to sense the 10-g SWME. Further studies are indicated to determine if routine screening for neuropathy and subsequent podiatric care for SSc patients with abnormalities can reduce pedal complications.
authors: Division of Rheumatology, Department of Internal Medicine, University of Utah, 4B200 SOM 30 N 1900 E, Salt Lake City, UT 84132, USA. Tracy.Frech@hsc.utah.edu
authors: Tracy M
authors: TM
authors: Frech
authors: Gordon
authors: G
authors: Smith
authors: Melissa
authors: M
authors: Reily
authors: James
authors: J
authors: Chamberlain
authors: Maureen A
authors: MA
authors: Murtaugh
authors: Jason
authors: J
authors: Penrod
authors: Michael J
authors: MJ
authors: Battistone
authors: Barry M
authors: BM
authors: Stults
mesh_terms: D000328:Adult; D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D015588:Observer Variation; D010523:Peripheral Nervous System Diseases / Q000150:complications / Q000175:diagnosis*; D015203:Reproducibility of Results; D012307:Risk Factors; D012595:Scleroderma, Systemic / Q000150:complications*; D014456:Ulcer / Q000503:physiopathology; D014732:Vibration
references: Arch Phys Med Rehabil. 1992 Sep;73(9):811-3
references: 1514889
references: Diabetes Metab Rev. 1991 Jun;7(2):120-8
references: 1794257
references: Diabetes Metab Res Rev. 2012 Feb;28 Suppl 1:225-31
references: 22271742
references: Endocr Metab Immune Disord Drug Targets. 2012 Jun;12(2):168-78
references: 22236028
references: J Rheumatol. 2011 Jul;38(7):1326-8
references: 21459952
references: Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 62):S15-8
references: 21050540
references: Diabetes Care. 1999 Mar;22(3):382-7
references: 10097914
references: J Rheumatol. 2012 Mar;39(3):524-31
references: 22247347
references: Neurosci Behav Physiol. 2007 Jan;37(1):1-6
references: 17180311
references: Diabetes Care. 2003 Sep;26(9):2604-8
references: 12941726
references: Ann Rheum Dis. 2009 May;68(5):609-10
references: 19366892
references: Muscle Nerve. 2003 Sep;28(3):330-5
references: 12929193
references: Diabetes Care. 2001 Feb;24(2):250-6
references: 11213874
references: J Fam Pract. 2000 Nov;49(11 Suppl):S17-29
references: 11093555
references: Scand J Rheumatol. 1999;28(4):260-1
references: 10503566
references: Int J Rheumatol. 2010;2010:
references: 20827313
references: Diabetes Care. 2010 Oct;33(10):2285-93
references: 20876709
references: Arthritis Rheum. 1980 May;23(5):581-90
references: 7378088
references: Curr Vasc Pharmacol. 2009 Jan;7(1):34-9
references: 19149638
references: Br J Dermatol. 2012 Feb;166(2):417-21
references: 21848685
references: Microvasc Res. 2008 Aug;76(2):124-31
references: 18602650
references: Atherosclerosis. 2011 Sep;218(1):13-8
references: 21763654
references: Curr Rheumatol Rep. 2009 Apr;11(2):103-10
references: 19296882
references: Diabetes Care. 2012 Jan;35 Suppl 1:S11-63
references: 22187469
references: Eur J Radiol. 2011 Mar;77(3):377-82
references: 19781886